to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Anthony Stedillie, Founder of CompassMD, ran into many obstacles during his entrepreneurial journey to create an online system that actively matches cancer patients with the right doctors for their individual needs. One of Stedillie’s biggest obstacles came at the start of CompassMD when deciding on a founding team.
Selecting a business incubator may not be as simple as you think. Read more from a healthcare business entrepreneur who shares what he learned from his experience.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
Healthcare business owners could learn a lot about disaster readiness from non-healthcare businesses, such as Waffle House. Yes, Waffle House.
Entrepreneurs are optimistic about 2012, with a general feeling that the worst of the Great Recession has passed, according to one survey. Read more about the survey's other findings.
Adam Coomes is a prime example of an entrepreneur who has seen the best of times and the worst of times. He has been a part of several startups and has gone through the peaks and valleys of these experiences. They've consisted of fast-paced ventures and ventures that have been put on the backburner. He has never worked in the corporate world and never intends to. Adam will always be an entrepreneur.
Ronald Lindsay, CEO of Zebra Biologics Inc., thinks changes in the biotech industry will lead to a trend of success for biotech companies. His company’s technology can be used as a platform to discover and develop bio-superior antibody therapeutics and complex drug targets. Zebra has just pulled in $9 million in its first investing round, and Lindsay thinks one of the biggest changes for the future of biotech is the availability of venture funding.
Global medical technology executives place a high value on quality, and it's that consistency of quality that keeps them up at night. Read more about the issue of quality in outsourcing.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.